$116.39
-6.76-5.49%
At close: Aug 28, 5:00 PM EST
$125.71
9.328.01%
After Hours: Aug 27, 9:12 AM EST
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Calculators
Compare Best Stocks
ProShares Ultra Nasdaq Biotechnology (BIB) Stock Price, Quote, News & History
BIBNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
107.73M
Fund Score
Loading...
Key Statistics
Open
$122.92
High
$122.92
52 Wk High
$126.40
AUM
107.73M
Dividend
$0.50
Ex-Div Date
Mar 25, 2026
Volume
12.95K
Market Cap
$53.04B
Mgmt Fee
0.75%
P/E Ratio
21.71
Prev. Close
$123.15
Low
$116.02
52 Wk Low
$54.85
Shares Out
1.63M
Yield
0.41%
Div. Freq
-
Avg. Volume Daily
11.08K
Beta
1.20
Avg. Expense Ratio
0.95%
P/B Ratio
4.62
Recent ProShares Ultra Nasdaq Biotechnology News
FAQ
Q
How do I buy ProShares Ultra Nasdaq Biotechnology (BIB) stock?
A
You can purchase shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) through any online brokerage.
Q
Who are ProShares Ultra Nasdaq Biotechnology (BIB) competitors?
A
There are no as such competitors for ProShares Ultra Nasdaq Biotechnology.
Q
What is the forecast, or price target, for ProShares Ultra Nasdaq Biotechnology (BIB) stock?
A
There is no analysis for ProShares Ultra Nasdaq Biotechnology to provide a consensus price target.
Q
What is the current price for ProShares Ultra Nasdaq Biotechnology (BIB)?
A
The stock price for ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB) is $125.71 last updated August 27, 2026 at 9:12 AM EDT.
Q
Does ProShares Ultra Nasdaq Biotechnology (BIB) pay a dividend?
A
There are no upcoming dividends for ProShares Ultra Nasdaq Biotechnology.
Q
When is ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) reporting earnings?
A
ProShares Ultra Nasdaq Biotechnology does not have any upcoming earnings scheduled.
Q
Is ProShares Ultra Nasdaq Biotechnology (BIB) going to split?
A
There is no upcoming split for ProShares Ultra Nasdaq Biotechnology.
Key Statistics
Open
$122.92
High
$122.92
52 Wk High
$126.40
AUM
107.73M
Dividend
$0.50
Ex-Div Date
Mar 25, 2026
Volume
12.95K
Market Cap
$53.04B
Mgmt Fee
0.75%
P/E Ratio
21.71
Prev. Close
$123.15
Low
$116.02
52 Wk Low
$54.85
Shares Out
1.63M
Yield
0.41%
Div. Freq
-
Avg. Volume Daily
11.08K
Beta
1.20
Avg. Expense Ratio
0.95%
P/B Ratio
4.62
About
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Low Growth |
| Investment Style | Trading-Leveraged Equity |
| Fund Inception | Apr 6, 2010 |
| Managers | Tarak Dave Michael Neches |
| Definition | Majority of stocks in this equity fund have average financial performance and low growth potential |
Investment Policy
The Fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target.
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved